Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 77 (PPIAP77)

Target
PPIAP77
Molecular classification
Pseudogene
01

Overview

Peptidylprolyl isomerase A pseudogene 77 (PPIAP77) is a human pseudogene related to the parental gene peptidylprolyl isomerase A (PPIA, also known as cyclophilin A). Pseudogenes such as PPIAP77 are classified as genomic DNA sequences similar to known genes but generally lack the ability to encode proteins due to mutations or deletions disrupting their coding potential. There are no known reports of PPIAP77 acting as a therapeutic target, biomarker, or being functionally implicated in human disease or physiology. This is distinct from other pseudogenes of PPIA such as PPIAP22, for which some regulatory roles have been suggested in disease, but no such roles or functions have been attributed to PPIAP77. The only information available from referenced gene and genomics databases indicates that PPIAP77 is annotated as a "pseudogene" for PPIA in humans, without functional characterization or recognized clinical or therapeutic relevance. There is no evidence that it encodes a protein or has any direct drug interactions, mechanisms of action, biomarker value, or safety concerns; pseudogenes typically do not produce functional proteins. The scientific literature does not currently report any biological, regulatory, or disease-related significance for this specific pseudogene (PPIAP77). In summary, PPIAP77 is a non-coding pseudogene corresponding to peptidylprolyl isomerase A, with no established biological, clinical, or therapeutic functions.

Other names
PPIA pseudogene 77
02

Biological functions

No confirmed biological function (pseudogene)
03

Disease associations

No reported disease associations

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 77 (PPIAP77).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 77 (PPIAP77).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call